Switzerland

1. Introduction Laws around the world impose strict data security obligations on organisations that process personal data, and in some cases require them to report data breaches to data protection aut...

In line with the rather cautious M A landscape seen in 2023, the Swiss M A market showed no significant upturn in 2024, although a strong increase of the deal volume could be observed.

1. Introduction Swiss contractual covered bonds emerged in the wake of the global financial crisis of 2008-2010 and have since established themselves as a cost-effective and crisis-resistant funding i...

The integration of environmental, social, and governance (ESG) factors into private equity (PE) strategies has transitioned from a regulatory or reputational consideration to a cornerstone of long-ter...

On June 30, 2025, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its investment into ULTIMA CAPITAL SA, a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA). As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Bakaso Holdings Limited at a contribution value of CHF 120.0 m in exchange for 2,000,000 newly-issued shares in Ultima. Bakaso indirectly owns various commercial properties valued at approximately EUR 133.7 m primarily in the food and beverage and retail sector located in the areas of Psarrou and Ano Mera, Mykonos, Greece, including the Nammos beach-bar restaurant and the seven-building Nammos Village retail area. As a result of the transaction, Yoda increased its shareholding in Ultima from previously approximately 53.8% to approximately 64.0% post-completion. Homburger advised Yoda on all aspects of the transaction. The Homburger team was led by Lorenzo Togni and included Jonas Stähli and Viviane Egli (all Corporate / M&A) as well as Claudia Suter and Philippe Weber (both Tax). Stefan Blunschi and Micha Frankhauser (both Corporate / M&A) also contributed to the transaction. Contact Nanding Susso / Marketing / [email protected]

On June 25, 2025, Idorsia Ltd published its public repurchase offer (the Exchange Offer) to exchange its CHF 200 m senior unsecured convertible bonds due 2025 and its CHF 600 m senior unsecured convertible bonds due 2028 (the Bonds). The Bonds will be exchanged for an offer consideration consisting of (i) a series of newly issued „Pay-If-You-Can“ notes with waterfall rankings issued by a Luxembourg special purpose subsidiary, which will be listed on the International Stock Exchange, (ii) shares of Idorsia Ltd and (iii) warrants of Idorsia Ltd. The Swiss Takeover Board has made determinations and granted exemptions regarding the Exchange Offer in its ruling dated June 5, 2025. The Exchange Offer is part of the holistic restructuring and refinancing of the Idorsia group announced by Idorsia Ltd on February 26, 2025. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Marco Rostetter (Corporate / M&A, Restructuring / Insolvency), Micha Fankhauser, Estelle Piccard and Anina Preusker (all Corporate / M&A) as well as Eduard De Zordi and Daniel Hulmann (both Capital Markets). Contact Johanna Schmid / Marketing / [email protected]

On June 19, 2025, Julius Baer Group Ltd. issued EUR 500 m notes (the Notes). The issuance occurred indirectly through the ELM issuance vehicle, a repackaging issuance entity incorporated in the Netherlands. The Notes will be listed on Euronext Dublin. For the Notes, UBS AG, London Branch, BNP PARIBAS, Citigroup Global Markets Europe AG and J.P. Morgan SE acted as Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and Eduard De Zordi (both Capital Markets). Tax aspects were covered by Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 27, 2025, BeOne Medicines Ltd., a global oncology company, officially completed its redomiciliation from the Cayman Islands to Basel, Switzerland, following shareholder approval on April 28, 2025. The redomiciliation to Switzerland strengthens BeOne’s presence and deepens its roots in a global biopharmaceutical hub, further enabling its growth strategy of bringing innovative medicines to patients around the world. BeOne Medicines Ltd.'s American Depositary Shares are listed on the Nasdaq Global Select Market, each representing 13 ordinary shares of BeOne Medicines Ltd., each having a par value of USD 0.0001 per share (the “Ordinary Shares”), the Ordinary Shares are listed on The Stock Exchange of Hong Kong Limited, and the Ordinary Shares traded in Renminbi are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The Homburger team was led by David Oser (Corporate / M&A, Capital Markets) and included Bianca Nedwed and Kaiyan Yeo (both Corporate / M&A, Capital Markets), Stefan Bindschedler and Benjamin Leisinger (Banking and Finance) as well as Stefan Oesterhelt and Juliette Buob (both Tax). Contact Johanna Schmid / Marketing / [email protected]